One of seven of Cancer Research UK’s (CRUK) Centres of Excellence in Radiotherapy Research, the CRUK RadNet Centre Glasgow includes three core laboratory teams of radiation researchers who work within the RadNet initiative to incentivize and encourage other...
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura at the CalDerm 2024 NorCal Conference at the Meritage Resort & Spa from May 3-5 in Napa, CA.
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions at the European Society for Radiotherapy and Oncology (ESTRO) Annual Meeting in Glasgow, UK, May 3-7, 2024, stand # 1070.
DermRay helps dermatology practices leverage the benefits of Xstrahl’s dual modality Radiant system to expand treatment options for NMSC. For more than a decade, radiation oncologists Ankit Agarwal, MD and David Greene, MD, at DermRay have been providing turnkey...
La radioterapia superficial y de ortovoltaje proporciona una opción de tratamiento eficaz para una amplia variedad de indicaciones médicas, incluidos el cáncer de piel no melanoma, algunas afecciones benignas e incluso cuidados paliativos. Únase a Xstrahl y al...
While SARRP is often used to investigate the effect of radiation therapy in preclinical oncology settings, it should be noted that the impact of radiation on normal tissues requires understanding and further research to mitigate both early and late effects. The use of...
The role of radiation in treating non-malignant diseases is currently undergoing an American Renaissance. Low-dose radiation therapy (LDRT) has been used successfully throughout the world for treating benign conditions for over a century, but its resurgence has been...
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Radiant Aura at the AOCD 2024 meeting, in Scottsdale, AZ. Radiant Aura is a new low-dose, X-ray based, dual modality radiation therapy for treating non-melanoma skin cancers (NMSC) and keloid scarring. Visit Xstrahl at AOCD 2024, booth # 22 at the Westin Kierland from April 11-14, 2024.
6th Conference on Small Animal Precision Image-Guided Radiotherapy April 8-10, 2024 Antwerp, Belgium Join Xstrahl and researchers around the world who study precision image-guided preclinical radiotherapy at this conference. Learn the latest in the field of...
Xstrahl's Medical Director, Dr. Richard Shaffer, recently spoke for a webinar hosted by Joint Pain Practice. He shares how low-dose radiotherapy can be used for osteoarthritis, and overviews the treatment process, risks, and efficacy. https://youtu.be/ab4iyfhN_L8...